Humming in Q1 I’ve had a rough year, but Revive (RVV.C) sure hasn’t. With a portfolio based around psychedelics, cannabis, and diseases – this company has made 3…
Psychedelics
Revive Therapeutics (RVV.C) advanced the December 21 deal with Newscope Capital (PHRM.C) past a binding LOI and into a purchase agreement to acquire psilocybin intellectual property from Newscope’s subsidiary,…
Mother nature Am I a true hippy, or do I have an impulsive personality that morphs and changes due to a lack of identity? My therapist thinks…
Our mental health is deteriorating More and more people are seeking help as anxiety, depression, and suicide are on the rise in 2021. According to a recent…
Ego death for ex. mining & cannabis CEOs Young and inexperienced Tony Robbins sociopaths are running about half of the current 37 publicly traded psychedelics companies. They are raising…
Xphyto Therapeutics (XPHY.C) subsidiary Xphyto Laboratories added mescaline to its list of psychedelic medicine programs today, according to a press release. Earlier this month the company brought Applied Pharmaceutical…
Numinus Wellness (NUMI.V) closed its previously announced acquisition of psychedelic programming operation, Mindspace Psychology Services today. Mindspace Wellbeing, the operational arm of Mindspace Psychology Services, is a well-being organization…
Algernon Pharmaceuticals (AGN.C) and Charles River Laboratories agreed to have the latter handle Algernon’s DMT pre-clinical studies for their stroke clinical research program today, according to a press release….
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature…
Core One Labs (COOL.C) signed a letter of intent today with Ketamine Infusion Centers of Texas (KICT) today to determine if the company would be an adequate fit for…